Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linong Ji

Showing results (391-400 of 588) with videos related to

Pageof 59
Sort By:
Chinese Medical Journal|April 3, 2025
Comparison of glucose fluctuation between metformin combined with acarbose or sitagliptin in Chinese patients with type 2 diabetes: A multicenter, randomized, active-controlled, open-label, parallel design clinical trialXiaoling Cai, Suiyuan Hu, Chu Lin, et al.
Annals of Translational Medicine|September 16, 2022
Thyroid autoantibody distribution in patients with latent autoimmune diabetes in youth: a multicenter, national surveyXixi Nan, Xia Li, Yufei Xiang, et al.
Frontiers in Immunology|April 8, 2022
GAD65 Antibody Epitopes and Genetic Background in Latent Autoimmune Diabetes in Youth (LADY)Yiman Peng, Xia Li, Yufei Xiang, et al.
Diabetologia|August 5, 2022
Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trialXiuying Zhang, Huahui Ren, Cuiling Zhao, et al.
Diabetes, Obesity & Metabolism|May 5, 2021
Effect of empagliflozin on cardiorenal outcomes and mortality according to body mass index: A subgroup analysis of the EMPA-REG OUTCOME trial with a focus on AsiaQiuhe Ji, Linong Ji, Yiming Mu, et al.
Scientific Reports|January 5, 2024
Plasma proteome profiling reveals the therapeutic effects of the PPAR pan-agonist chiglitazar on insulin sensitivity, lipid metabolism, and inflammation in type 2 diabetesXingyue Wang, You Wang, Junjie Hou, et al.
Diabetes Technology & Therapeutics|October 27, 2021
Screening Strategy for Islet Autoantibodies in Diabetes Patients of Different AgesXixi Nan, Xia Li, Yufei Xiang, et al.
Frontiers in Endocrinology|October 31, 2022
Contribution of mitochondrial gene variants in diabetes and diabetic kidney diseaseMeng Li, Siqian Gong, Xueyao Han, et al.
Frontiers in Endocrinology|February 26, 2024
Preserved C-peptide is common and associated with higher time in range in Chinese type 1 diabetesWei Liu, Yayu Fang, Xiaoling Cai, et al.
Journal of Diabetes|June 13, 2023
The effects of daily dose and treatment duration of metformin on the prevalence of vitamin B12 deficiency and peripheral neuropathy in Chinese patients with type 2 diabetes mellitus: A multicenter cross-sectional studyLeili Gao, Xingwu Ran, Xuejun Liu, et al.
Pageof 59

Showing results (391-400 of 588) with videos related to

Sort By:
Pageof 59
Chinese Medical Journal|April 3, 2025
Comparison of glucose fluctuation between metformin combined with acarbose or sitagliptin in Chinese patients with type 2 diabetes: A multicenter, randomized, active-controlled, open-label, parallel design clinical trialXiaoling Cai, Suiyuan Hu, Chu Lin, et al.
Annals of Translational Medicine|September 16, 2022
Thyroid autoantibody distribution in patients with latent autoimmune diabetes in youth: a multicenter, national surveyXixi Nan, Xia Li, Yufei Xiang, et al.
Frontiers in Immunology|April 8, 2022
GAD65 Antibody Epitopes and Genetic Background in Latent Autoimmune Diabetes in Youth (LADY)Yiman Peng, Xia Li, Yufei Xiang, et al.
Diabetologia|August 5, 2022
Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trialXiuying Zhang, Huahui Ren, Cuiling Zhao, et al.
Diabetes, Obesity & Metabolism|May 5, 2021
Effect of empagliflozin on cardiorenal outcomes and mortality according to body mass index: A subgroup analysis of the EMPA-REG OUTCOME trial with a focus on AsiaQiuhe Ji, Linong Ji, Yiming Mu, et al.
Scientific Reports|January 5, 2024
Plasma proteome profiling reveals the therapeutic effects of the PPAR pan-agonist chiglitazar on insulin sensitivity, lipid metabolism, and inflammation in type 2 diabetesXingyue Wang, You Wang, Junjie Hou, et al.
Diabetes Technology & Therapeutics|October 27, 2021
Screening Strategy for Islet Autoantibodies in Diabetes Patients of Different AgesXixi Nan, Xia Li, Yufei Xiang, et al.
Frontiers in Endocrinology|October 31, 2022
Contribution of mitochondrial gene variants in diabetes and diabetic kidney diseaseMeng Li, Siqian Gong, Xueyao Han, et al.
Frontiers in Endocrinology|February 26, 2024
Preserved C-peptide is common and associated with higher time in range in Chinese type 1 diabetesWei Liu, Yayu Fang, Xiaoling Cai, et al.
Journal of Diabetes|June 13, 2023
The effects of daily dose and treatment duration of metformin on the prevalence of vitamin B12 deficiency and peripheral neuropathy in Chinese patients with type 2 diabetes mellitus: A multicenter cross-sectional studyLeili Gao, Xingwu Ran, Xuejun Liu, et al.
Pageof 59